BR0111319A - Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário - Google Patents

Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário

Info

Publication number
BR0111319A
BR0111319A BR0111319-4A BR0111319A BR0111319A BR 0111319 A BR0111319 A BR 0111319A BR 0111319 A BR0111319 A BR 0111319A BR 0111319 A BR0111319 A BR 0111319A
Authority
BR
Brazil
Prior art keywords
compound
preparing
salt
pyrimidine
pharmacists
Prior art date
Application number
BR0111319-4A
Other languages
English (en)
Inventor
Ulf Larsson
Mattias Magnusson
Tribor Musil
Andreas Palmgren
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244413&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0111319(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0111319A publication Critical patent/BR0111319A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"COMPOSTO, PROCESSO PARA PREPARAR UM COMPOSTO, USO DE UM COMPOSTO, PROCESSO PARA PREPARAR UM SAL DE UM COMPOSTO, E, COMPOSTO INTERMEDIáRIO". A presente invenção refere-se a um composto de pirimidina (I) útil como um intermediário farmacêutico, a um processo para preparar o referido composto de pirimidina, a um intermediário usado no referido processo, e ao uso do referido composto de pirimidina na preparação deprodutos farmacêuticos.
BR0111319-4A 2000-06-02 2001-05-31 Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário BR0111319A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0013488.2A GB0013488D0 (en) 2000-06-02 2000-06-02 Chemical compound
SE0002102A SE0002102D0 (sv) 2000-06-02 2000-06-06 Chemical compound
PCT/SE2001/001241 WO2001092263A1 (en) 2000-06-02 2001-05-31 Novel triazolo pyrimidine compounds

Publications (1)

Publication Number Publication Date
BR0111319A true BR0111319A (pt) 2003-06-03

Family

ID=26244413

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111319-4A BR0111319A (pt) 2000-06-02 2001-05-31 Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário

Country Status (36)

Country Link
US (6) US7067663B2 (pt)
EP (1) EP1299390B1 (pt)
JP (1) JP4947870B2 (pt)
KR (2) KR100814229B1 (pt)
CN (3) CN100354268C (pt)
AR (1) AR028605A1 (pt)
AT (1) ATE386039T1 (pt)
AU (4) AU6287601A (pt)
BG (1) BG65866B1 (pt)
BR (1) BR0111319A (pt)
CA (1) CA2408914C (pt)
CY (1) CY1108101T1 (pt)
CZ (3) CZ302645B6 (pt)
DE (1) DE60132776T2 (pt)
DK (1) DK1299390T3 (pt)
EE (1) EE05223B1 (pt)
ES (1) ES2299487T3 (pt)
GB (1) GB0013488D0 (pt)
HK (1) HK1053122A1 (pt)
HU (1) HU229281B1 (pt)
IL (3) IL152776A0 (pt)
IS (1) IS2600B (pt)
MX (2) MXPA02011793A (pt)
MY (1) MY131942A (pt)
NO (1) NO324266B1 (pt)
NZ (1) NZ522637A (pt)
PL (3) PL211318B1 (pt)
PT (1) PT1299390E (pt)
RU (1) RU2295526C2 (pt)
SE (1) SE0002102D0 (pt)
SI (1) SI1299390T1 (pt)
SK (1) SK286845B6 (pt)
TW (1) TWI285203B (pt)
UA (1) UA73182C2 (pt)
WO (1) WO2001092263A1 (pt)
ZA (1) ZA200209068B (pt)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
SE0401001D0 (sv) 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
SE0400873D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
GB0615619D0 (en) * 2006-08-05 2006-09-13 Astrazeneca Ab Chemical process for preparation of intermediates
GB0615620D0 (en) * 2006-08-05 2006-09-13 Astrazeneca Ab A process for the preparation of optically active intermediates
EP2081433A2 (en) * 2006-10-31 2009-07-29 Janssen Pharmaceutica N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
TWI496776B (zh) * 2007-11-15 2015-08-21 Astrazeneca Ab 製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法
US8563755B2 (en) * 2008-09-09 2013-10-22 Astrazeneca Ab Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates
USRE49686E1 (en) 2008-09-19 2023-10-10 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use of same
CN101977842A (zh) * 2009-03-02 2011-02-16 卡勒拉公司 气流多污染物控制***和方法
JP2013500347A (ja) 2009-07-27 2013-01-07 オースペックス ファーマシューティカルズ，インク． Ｐ２ｙ１２受容体のシクロプロピルモジュレーター
EP2305376A1 (en) 2009-09-23 2011-04-06 Lonza Ltd. Process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds
EP2536695A1 (en) 2010-02-16 2012-12-26 Actavis Group Ptc Ehf Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
AU2011244023A1 (en) 2010-04-20 2012-10-25 Actavis Group Ptc Ehf Novel process for preparing phenylcyclopropylamine derivatives using novel intermediates
WO2012001531A2 (en) 2010-06-30 2012-01-05 Actavis Group Ptc Ehf Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
WO2012063126A2 (en) 2010-11-09 2012-05-18 Actavis Group Ptc Ehf Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
RU2013133879A (ru) 2010-12-20 2015-01-27 Актавис Груп Птс Ехф НОВЫЕ СПОСОБЫ ПОЛУЧЕНИЯ ТРИАЗОЛО[4, 5-d]ПИРИМИДИНА, ЕГО ПРОИЗВОДНЫЕ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ
BR112013025680A2 (pt) * 2011-04-06 2017-01-03 Teva Pharma Novos intermediários e processos para preparar ticagrelor
CN102731467B (zh) * 2011-04-15 2015-12-16 博瑞生物医药（苏州）股份有限公司 替卡格雷的中间体及制备替卡格雷的方法
JP6023795B2 (ja) * 2011-05-13 2016-11-09 アストラゼネカ アクチボラグ ベンジル［（３ａＳ，４Ｒ，６Ｓ，６ａＲ）−６−ヒドロキシ−２，２−ジメチルテトラヒドロ−３ａＨ−シクロペンタ［ｄ］［１，３］ジオキソル−４−イル］カルバメートの調製方法および該方法における中間体
WO2012172426A1 (en) 2011-06-15 2012-12-20 Actavis Group Ptc Ehf Improved process for preparing cyclopentylamine derivatives and intermediates thereof
CN104024229B (zh) 2011-09-14 2016-08-31 力奇制药公司 ***并嘧啶化合物的合成
EP2570405A1 (en) 2011-09-14 2013-03-20 LEK Pharmaceuticals d.d. Synthesis of Triazolopyrimidine Compounds
EP2586773A1 (en) 2011-10-27 2013-05-01 LEK Pharmaceuticals d.d. Synthesis of Triazolopyrimidine Compounds
WO2013060837A1 (en) 2011-10-27 2013-05-02 Lek Pharmaceuticals D.D. Synthesis of triazolopyrimidine compounds
CA2855242A1 (en) 2011-11-30 2013-06-06 Actavis Group Ptc Ehf Novel crystalline form of ticagrelor and process for the preparation thereof
US9278972B2 (en) 2011-12-23 2016-03-08 Lek Pharmaceuticals D.D. Synthesis of triazolopyrimidine compounds
EP2628721A1 (en) 2012-02-20 2013-08-21 LEK Pharmaceuticals d.d. Synthesis of 2-(3,4-difluorophenyl)cyclopropanecarboxylic acid
CN104603098B (zh) * 2012-03-30 2016-06-29 桑多斯股份公司 2-(3,4-二氟苯基)环丙胺衍生物和盐的合成
EP2644590A1 (en) 2012-03-30 2013-10-02 LEK Pharmaceuticals d.d. Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts
WO2013150495A2 (en) * 2012-04-05 2013-10-10 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
WO2013163892A1 (en) * 2012-05-02 2013-11-07 Sunshine Lake Pharma Co., Ltd. Novel triazolo pyrimidine compounds and a process of preparation thereof
CN102659815B (zh) * 2012-05-04 2013-07-17 开原亨泰制药股份有限公司 一种制备选择性抗凝血药替卡格雷及其中间体的方法
CN102675321B (zh) * 2012-05-11 2014-12-10 上海皓元化学科技有限公司 一种替卡格雷的制备方法
EP2666771A1 (en) 2012-05-24 2013-11-27 LEK Pharmaceuticals d.d. Synthesis of Aminocyclopentanetriol Derivatives
WO2014023681A1 (en) * 2012-08-06 2014-02-13 Enantia, S.L. A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside
CN103588674B (zh) * 2012-08-14 2015-02-11 上海医药工业研究院 一种具有光学活性的环丙烷酰阱化合物、其制备和应用
CN103626743B (zh) * 2012-08-23 2018-06-08 广东东阳光药业有限公司 替卡格雷的新型中间体及其制备方法
CN102875537A (zh) * 2012-09-10 2013-01-16 常州制药厂有限公司 一种新的抗血栓药物的制备方法
WO2014083139A1 (en) 2012-11-29 2014-06-05 Actavis Group Ptc Ehf Novel amorphous form of ticagrelor
WO2014086291A1 (zh) * 2012-12-06 2014-06-12 博瑞生物医药技术(苏州)有限公司 一种制备替卡格雷的方法及其中间体
CN104341402B (zh) * 2013-07-23 2018-04-27 博瑞生物医药（苏州）股份有限公司 一种制备替卡格雷中间体的方法
CN103848834B (zh) * 2012-12-06 2017-09-22 博瑞生物医药（苏州）股份有限公司 一种制备替卡格雷的方法及其中间体
IN2012MU03723A (pt) 2012-12-31 2015-07-10 Megafine Pharma P Ltd
CN103936767B (zh) * 2013-01-23 2016-08-03 上海医药工业研究院 一种制备化合物(1r,2s,6s,7s)-4,4-二甲基-9-苯甲基-3,5,8-三氧杂-9-氮杂三环[5.2.1.02.6]葵烷的方法
CZ307217B6 (cs) 2013-03-14 2018-04-04 Zentiva, K.S. Zlepšený způsob výroby a nové intermediáty syntézy ticagreloru
ITMI20130487A1 (it) 2013-03-29 2014-09-30 Chemo Res S L Alchilazione selettiva di ciclopentilalcoli
CN104098553B (zh) 2013-04-10 2017-11-28 江苏恒瑞医药股份有限公司 替格瑞洛的中间体及其制备方法和替格瑞洛的制备方法
CN103275056B (zh) * 2013-05-24 2015-06-17 浙江普洛医药科技有限公司 一种替卡格雷中间体的制备方法
WO2014195861A2 (en) * 2013-06-04 2014-12-11 Dr. Reddy’S Laboratories Limited Preparation of ticagrelor
CN104230818B (zh) * 2013-06-06 2018-01-12 郝聪梅 替卡格雷中间体的改进制备方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
CN103275087A (zh) * 2013-06-28 2013-09-04 南京工业大学 一种三氮唑并嘧啶类衍生物及其制备方法
CN104059069B (zh) * 2013-08-22 2016-08-10 北京康立生医药技术开发有限公司 一种替卡格雷的制备方法
CN104592237A (zh) * 2013-10-31 2015-05-06 徐州万邦金桥制药有限公司 一种抗凝血药替格瑞洛的合成方法
CN103588750B (zh) * 2013-11-07 2014-11-26 苏州明锐医药科技有限公司 替卡格雷中间体的制备方法
CZ2013866A3 (cs) 2013-11-08 2015-05-20 Zentiva, K.S. Způsob výroby a nová krystalická forma intermediátu syntézy ticagreloru
CN103588712B (zh) * 2013-11-08 2016-06-08 南京欧信医药技术有限公司 一种嘧啶类化合物及其制备方法、和应用
CN104710425B (zh) * 2013-12-16 2019-06-14 石药集团中奇制药技术（石家庄）有限公司 一种替格瑞洛新结晶及其制备方法
CN104744424B (zh) * 2013-12-27 2018-12-25 博瑞生物医药（苏州）股份有限公司 一种替卡格雷中间体的制备方法
CN103923020A (zh) * 2014-04-02 2014-07-16 黄河三角洲京博化工研究院有限公司 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法
CN103992323B (zh) * 2014-04-18 2017-03-29 南通常佑药业科技有限公司 一种替格瑞洛的制备方法
WO2015162630A1 (en) 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
WO2015193165A1 (en) 2014-06-18 2015-12-23 Flamma Spa Process for the preparation of triazolo[4,5-d] pyrimidine cyclopentane compounds
WO2016001851A1 (en) * 2014-07-02 2016-01-07 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
CN104193748A (zh) * 2014-08-14 2014-12-10 严白双 一种替卡格雷的合成方法
WO2016030704A1 (en) * 2014-08-30 2016-03-03 Cipla Limited Solid form of intermediate of ticagrelor
CN105801583A (zh) * 2014-12-31 2016-07-27 徐州万邦金桥制药有限公司 一种替格瑞洛的纯化方法
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
WO2016117852A2 (ko) * 2015-01-22 2016-07-28 동아에스티 주식회사 티카그렐러 제조방법 및 이를 위한 신규한 중간체
CN105968113B (zh) * 2015-03-12 2019-06-07 四川海思科制药有限公司 一种***并嘧啶衍生物及其应用
CN105153167B (zh) * 2015-09-06 2017-09-19 惠州信立泰药业有限公司 一种替格瑞洛结晶及含有该结晶的药物组合物
CN105198864B (zh) * 2015-10-21 2018-11-06 华仁药业股份有限公司 一种环戊基嘧啶化合物的无溶剂制备方法
WO2017072790A1 (en) * 2015-10-26 2017-05-04 Avra Laboratories Pvt. Ltd. An improved process for synthesis of ticagrelor
CN105669681A (zh) * 2016-04-11 2016-06-15 成都华宇制药有限公司 一种替格瑞洛的合成方法
CN106543191B (zh) * 2016-10-28 2019-03-01 天津红日药业股份有限公司 一种替格瑞洛制备工艺
CN107337675A (zh) * 2017-06-03 2017-11-10 湖南天济草堂制药股份有限公司 一种制备替格瑞洛的改进方法
CN107382953A (zh) * 2017-07-25 2017-11-24 安徽诺全药业有限公司 一种制备多取代环戊烷衍生物的方法
CN108689984B (zh) * 2018-05-02 2019-09-20 淮阴工学院 一种替格瑞洛中间体的生物合成方法及其中间体
CN110894184B (zh) * 2019-11-25 2022-02-18 安徽一帆香料有限公司 一种基于绿色环保的替格瑞洛中间体的制备方法
EP3919497A1 (en) 2020-06-04 2021-12-08 Zaklady Farmaceutyczne Polpharma S.A. Process for the preparation of ticagrelor
CN112457316B (zh) * 2020-11-05 2022-04-12 南通常佑药业科技有限公司 一种应用连续流反应技术制备替卡格雷高级中间体的方法
CN112724119B (zh) * 2020-12-30 2022-05-03 江苏恒沛药物科技有限公司 一种替卡格雷关键中间体的合成方法
CN115160320B (zh) * 2022-06-27 2024-05-07 南通常佑药业科技有限公司 一种手性嘧啶并***类替格瑞洛的制备方法
CN115785058B (zh) * 2022-12-09 2024-05-03 广州康瑞泰药业有限公司 一种合成替格瑞洛五元环中间体的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3040406A1 (de) * 1980-10-27 1982-05-27 Degussa Ag, 6000 Frankfurt Verfahren zur gewinnung von n-tert-alkylaminen und ameisensaeureestern
GB8916477D0 (en) 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
EP0410660A1 (en) * 1989-07-24 1991-01-30 Glaxo Group Limited Cyclopentane derivatives
CA2107667A1 (en) * 1991-04-06 1992-10-07 Anthony Howard Ingall Atp analogues
US5654285A (en) * 1991-04-06 1997-08-05 Astra Pharmaceuticals Limited ADP and ATP analogues, process for making and administration to inhibit ADP-induced platelet aggregation
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
EP0840740B1 (en) * 1995-07-11 2002-05-02 AstraZeneca AB New inhibitors of platelet aggregation
US6297232B1 (en) * 1996-12-20 2001-10-02 Astrazeneca Ab Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
AR017014A1 (es) * 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
CN1291193A (zh) 1998-02-17 2001-04-11 阿斯特拉曾尼卡英国有限公司 新的***并(4,5－d)嘧啶化合物
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
CZ20002947A3 (cs) * 1999-02-05 2000-11-15 Astrazeneca Uk Limited Nové triazolo(4,5-d)pyrimidiny, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound

Also Published As

Publication number Publication date
HK1053122A1 (en) 2003-10-10
CY1108101T1 (el) 2014-02-12
BG107333A (bg) 2003-07-31
BG65866B1 (bg) 2010-03-31
CZ302644B6 (cs) 2011-08-10
GB0013488D0 (en) 2000-07-26
ATE386039T1 (de) 2008-03-15
JP2003535093A (ja) 2003-11-25
SK16832002A3 (sk) 2003-06-03
US20060041132A1 (en) 2006-02-23
US20070049755A1 (en) 2007-03-01
AU6287601A (en) 2001-12-11
AU2010200461A1 (en) 2010-02-25
SK286845B6 (sk) 2009-06-05
KR20030007828A (ko) 2003-01-23
CZ303162B6 (cs) 2012-05-09
US20080234481A1 (en) 2008-09-25
NO324266B1 (no) 2007-09-17
CA2408914A1 (en) 2001-12-06
CZ302645B6 (cs) 2011-08-10
KR20080003458A (ko) 2008-01-07
ES2299487T3 (es) 2008-06-01
CZ20023919A3 (cs) 2003-05-14
AR028605A1 (es) 2003-05-14
ZA200209068B (en) 2003-12-02
RU2295526C2 (ru) 2007-03-20
US7381828B2 (en) 2008-06-03
AU2010200461B2 (en) 2011-08-18
SI1299390T1 (sl) 2008-06-30
EE200200669A (et) 2004-06-15
PL392726A1 (pl) 2010-12-06
DE60132776T2 (de) 2009-02-12
PL212128B1 (pl) 2012-08-31
UA73182C2 (en) 2005-06-15
CN1432017A (zh) 2003-07-23
IS2600B (is) 2010-04-15
NZ522637A (en) 2004-09-24
MY131942A (en) 2007-09-28
IL225893A (en) 2015-08-31
TWI285203B (en) 2007-08-11
PL211318B1 (pl) 2012-05-31
CN1200940C (zh) 2005-05-11
NO20025719L (no) 2003-02-03
US7067663B2 (en) 2006-06-27
AU2007200776B2 (en) 2009-11-19
SE0002102D0 (sv) 2000-06-06
HUP0302345A3 (en) 2007-10-29
KR100802884B1 (ko) 2008-02-13
NO20025719D0 (no) 2002-11-28
MX336939B (es) 2016-02-08
EE05223B1 (et) 2009-10-15
KR100814229B1 (ko) 2008-03-17
EP1299390A1 (en) 2003-04-09
EP1299390B1 (en) 2008-02-13
AU2001262876B2 (en) 2007-03-01
DK1299390T3 (da) 2008-05-26
PL392725A1 (pl) 2010-12-06
US20110218330A1 (en) 2011-09-08
JP4947870B2 (ja) 2012-06-06
PT1299390E (pt) 2008-04-17
MXPA02011793A (es) 2003-04-10
PL359183A1 (en) 2004-08-23
CA2408914C (en) 2009-12-29
PL210375B1 (pl) 2012-01-31
HUP0302345A2 (hu) 2003-11-28
CN1680340A (zh) 2005-10-12
US20100004444A1 (en) 2010-01-07
WO2001092263A1 (en) 2001-12-06
CN100354268C (zh) 2007-12-12
HU229281B1 (en) 2013-10-28
IL152776A (en) 2013-06-27
IL225893A0 (en) 2013-06-27
IL152776A0 (en) 2003-06-24
US8273879B2 (en) 2012-09-25
AU2007200776A1 (en) 2007-03-15
US20030148888A1 (en) 2003-08-07
DE60132776D1 (de) 2008-03-27
CN101143864A (zh) 2008-03-19
IS6614A (is) 2002-11-14

Similar Documents

Publication Publication Date Title
BR0111319A (pt) Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
BR0111667A (pt) Novos compostos
BR0017030B8 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
BRPI0407734A (pt) derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR0016227A (pt) Derivados de adamantano
BR9912240A (pt) Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos
BR0108678A (pt) Novos compostos
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
BR9911914B1 (pt) n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
PT1222163E (pt) 1,1-bifenil-2-carboxamidas substituidas na posicao 2 processo para a sua preparacao, sua utilizacao como medicamento, bem como preparacoes farmaceuticas contendo estas
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
BRPI0607614A2 (pt) sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR0211729A (pt) Compostos, composições farmacêuticas, processo para fabricar compostos, uso de um ou mais compostos, e, processo para fabricar composições farmacêuticas
BR0208169A (pt) Composto quìmicos
BR0111669A (pt) Novos compostos
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0113399A (pt) Processo para a preparação de um suplemento de ração animal, suplemento de ração animal, e, uso do mesmo
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE C07D 487/04.

Ipc: C07B 61/00 (2006.01), C07D 239/00 (2006.01), C07D

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]